3.19 USD
▼+0.07-0.16%
盘后 3.18 -0.47%
2026-08-03
市值
$12.83M
市盈率
—
EPS
-4.19
股息率
—
52 周区间
2.07 – 12.50
成交量
66.52K
Beta
-1.03
目标价
10.00
52W 低 2.0752W 高 12.50
价格走势
公司简介
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SC...